Sponsors (2)
The bill aims to accelerate U.S. biotechnology commercialization and improve regulatory coordination and public outreach, but does so by creating a quasi‑private, federally funded foundation that raises modest taxpayer costs and risks of private influence, duplication, and complications around foreign funding.
Researchers, startups, universities, and U.S. biotech exporters will gain increased funding, training, partnerships, and international standards engagement that accelerate biotechnology commercialization and improve market access abroad.
Federal agencies and state governments will receive coordinated technical assistance and direct support to improve regulatory processes and interagency collaboration, which can streamline approvals and policy alignment.
Parents, families, and students will have expanded public engagement, education, and outreach programs that can raise public understanding and acceptance of biotechnology products.
Taxpayers will finance a new nonprofit with an initial $4 million annually and possible additional appropriations, creating a direct federal cost for the program.
Private funding and industry partners could influence the Foundation's priorities despite conflict rules, raising risks of bias in publicly funded activities and favoring private interests.
Creating a quasi-private foundation risks duplicating existing federal programs and generating coordination challenges with agencies and state governments if roles and alignment are not clearly managed.
Based on analysis of 2 sections of legislative text.
Creates a nonprofit under NSF to accelerate biotech commercialization via partnerships, agency support, education, studies, and market/regulatory engagement.
Introduced September 3, 2025 by Alejandro Padilla · Last progress September 3, 2025
Creates a new nonprofit, the Foundation for Enabling Biotechnology Innovation, to speed U.S. commercialization of biotechnology products by supporting federal agency capacity, fostering public–private partnerships, running education and fellowship programs, funding studies and projects, and facilitating market and international engagement. The Foundation will be governed by a Board (with at least five voting members who are not federal employees), may receive and administer private funds subject to foreign-donor restrictions, must obtain tax-exempt status, and is explicitly not a federal agency or regulator.